US Supreme Court backs ‘rule-of-reason’ for pay-for-delay
17-06-2013
The US Court of Appeals for the Second Circuit ruled on April 29 that a so-called ‘reverse payment patent settlement’ between pharmaceutical company Bayer and three generic drugs companies did not violate US antitrust laws.
If you have already subscribed please login.
If you have any technical issues please email tech support.
US, Court of Appeals, Bayer, reverse, payment, patents
